article thumbnail

The Impact of Agile In The Pharmaceutical Industry

Electronic Health Reporter

As many know, the pharmaceutical industry is heavily regulated and specialized, with slow drug-development timelines, strict processes and quality requirements, and rigid silos. The article The Impact of Agile In The Pharmaceutical Industry appeared first on electronichealthreporter.com.

article thumbnail

Pharmaceutical industry rips 'draconian' price negotiation provision

Fierce Healthcare

The Biden administration and federal regulators may be taking a victory lap following the unveiling of the Centers for Medicare & Medicaid Services’ (CMS') price negotiations list, but major pl | Critics of President Joe Biden's policies to rein in prices for 10 Medicare Part D drugs believe the policy is "draconian" and will (..)

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Gains and Pains of Using AI in the Pharmaceutical Industry

HIT Consultant

Michael Galarnyk, AI Evangelist at cnvrg.io. The costs for drug discovery and development are skyrocketing, but AI (artificial intelligence) is introducing new efficiencies to help find effective treatments faster. A study in 2020 concluded that the estimated median capitalized research and development cost per product was $985 million.

article thumbnail

Workforce training platform Transform launches to the pharmaceuticals industry

Mobi Health News

The platform provides solutions in energy health and safety training and now brings its training expertise to the pharmaceuticals sector.

article thumbnail

Appeals court affirms Arkansas law against drugmakers' 340B contract pharmacy restrictions

Fierce Healthcare

The three-judge panel's ruling, which could be appealed, could spur action in other states.

article thumbnail

Mayo Clinic, LifePoint Health sue pharmas over 'pay for delay' deals keeping blood cancer drug prices high

Fierce Healthcare

The Mayo Clinic and LifePoint Health believe that collusion within pharmaceutical industry forced their organizations to overpay for the multiple myeloma drug Revlimid, and are petitioning the cour | The health systems said agreements between Revlimid's owners, Celgene and Bristol-Myers Squibb, and other drugmakers that delayed full production (..)

article thumbnail

Eliquis, Jardiance, Xarelto headline CMS' price negotiation list

Fierce Healthcare

CMS released its highly anticipated list of 10 drugs subject to Medicare price negotiations Tuesday, which includes popular blood clot prevention drugs Eliquis and Xarelto and diabetes drugs Jardia | CMS released its highly anticipated list of 10 drugs subject to Medicare price negotiations Tuesday, a big first step in pushing back against the pharmaceutical (..)